Core Insights - Algeria's pharmaceutical industry has developed significantly, with over 200 production units meeting approximately 80% of the national drug demand, including 10 factories dedicated to cancer medications [1] - The African Ministerial Conference on Pharmaceutical Production held in Algeria resulted in positive outcomes, gathering representatives from 29 African countries and various international organizations, highlighting the strategic importance of ensuring drug accessibility in Africa [1] - Algeria has signed five export contracts totaling $10 million with countries like Mauritania, Libya, and Senegal during the conference, showcasing its capability in local drug production and medical supplies [1] Industry Developments - Algeria is not only meeting domestic market needs but is also capable of supplying to markets outside Africa, having already exported drugs, particularly insulin, to Middle Eastern countries such as Oman and Saudi Arabia [2] - The country is increasing investments in medical supplies, focusing on digitalizing processes, simplifying approval procedures, and creating precise industrial planning to enhance local production capacity and reduce import costs [2]